(+-)-Naringenin
Specifications
67604-48-2CAS Number
266-769-1EC Number
5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-oneIUPAC Name
C15H12O5Chemical Formula
272.25 g/molMolecular Weight
67604-48-2; 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; DTXSID50274239; (+-)-naringenin; RefChem:528240; DTXCID50196624; 266-769-1; (+/-)-Naringenin; 4',5,7-Trihydroxyflavanone; rac Naringenin; ( inverted exclamation markA)-Naringenin; 93602-28-9; (R,S)-Naringenin; (-)-Naringenin; 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; (+)-naringenin; MFCD00006844; C15H12O5; CHEMBL32571; rac-Naringenin; MLS000028739; MLS000738094; NSC11855; NSC34875; SMR000059039; 4',7-Trihydroxyflavanone; NSC 34875; 5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one; Flavanone,5,7-trihydroxy-; ( inverted exclamation markA)-Naringenin (Standard); (+/-)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; Naringenin?; CCRIS 8135; MFCD00870553; 4H-1-Benzopyran-4-one,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-; (?-Naringenin; 4H-1-Benzopyran-4-one,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (S)-; S-Dihydrogenistein; 4H-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (S)-; Naringenin (NAR); Prestwick_531; (??)-Naringenin; EINECS 266-769-1; Opera_ID_106; Prestwick0_000466; Prestwick1_000466; Prestwick2_000466; Prestwick3_000466; Oprea1_194140; SCHEMBL20571; BSPBio_000572; MLS001146907; 4',5,7-Trihydroxy-flavanon; SPBio_002511; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one; BPBio1_000630; MEGxp0_000358; orb1297626; orb3140909; SCHEMBL25894738; ACon1_000582; BDBM19461; GTPL10298; 4',5,7-trihydroxyflavan-4-one; TMS2171; (+/-)-Naringenin, >=95%; HMS1569M14; HMS2096M14; HMS2231O18; HMS3352B08; HMS3373N07; HMS3656G15; Naringenin, natural (US), 98%; HY-W011641R; EBC-03890; NSC815094; SBB006461; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one; AKOS015895052; (+/-)-Naringenin, analytical standard; CS-W012357; FN01176; HY-W011641; KS-5142; NSC-815094; SB17305; (+/-)-Naringenin, ~95% (HPCE); SMP1_000060; 4',5,7-Trihydroxy-2,3-dihydroflavone; NCGC00017346-02; NCGC00017346-03; NCGC00017346-04; NCGC00017346-09; NCGC00095963-01; NCGC00095963-02; NCGC00095963-03; AC-20273; ST057236; SY049933; SY075819; DB-057415; (R,S)-Naringenin 1000 |Ig/mL in Acetone; N0072; NS00003069; (R,S)-Naringenin 1000 microg/mL in Acetone; EN300-717813; S00279; AE-848/32605045; F320310; 5,7-Dihydroxy-2-(4-hydroxy-phenyl)-chroman-4-one; BRD-A94669766-001-02-6; BRD-A94669766-001-04-2; Q57826857; Z1741982267; EC19096C-4404-4A16-9BF9-92F9F358E005; ( )-Naringenin; 4?,5,7-Trihydroxyflavanone; H-1-benzopyran-4-one; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one, (S)- #Synonyms
